BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10573324)

  • 1. Dextromethorphan and diabetic neuropathy.
    Criner TM; Perdun CS
    Ann Pharmacother; 1999 Nov; 33(11):1221-3. PubMed ID: 10573324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: efficacy and dose-response trials.
    Sang CN; Booher S; Gilron I; Parada S; Max MB
    Anesthesiology; 2002 May; 96(5):1053-61. PubMed ID: 11981142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A qualitative systematic review of the role of N-methyl-D-aspartate receptor antagonists in preventive analgesia.
    McCartney CJ; Sinha A; Katz J
    Anesth Analg; 2004 May; 98(5):1385-400, table of contents. PubMed ID: 15105220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dextromethorphan: a review of N-methyl-d-aspartate receptor antagonist in the management of pain.
    Siu A; Drachtman R
    CNS Drug Rev; 2007; 13(1):96-106. PubMed ID: 17461892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of efficacy of dextromethorphan in managing alcohol withdrawal: a preliminary report of a randomized, double-blind, placebo-controlled trial.
    Huang MC; Chen CH; Pan CH; Lin SK
    J Clin Psychopharmacol; 2014 Feb; 34(1):149-52. PubMed ID: 24346753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia.
    Nelson KA; Park KM; Robinovitz E; Tsigos C; Max MB
    Neurology; 1997 May; 48(5):1212-8. PubMed ID: 9153445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale and design of a randomized double-blind clinical trial in breast cancer: dextromethorphan in chemotherapy-induced peripheral neuropathy.
    Martin E; Morel V; Joly D; Villatte C; Delage N; Dubray C; Pereira B; Pickering G
    Contemp Clin Trials; 2015 Mar; 41():146-51. PubMed ID: 25636304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of dextromethorphan/quinidine at two dosage levels for diabetic neuropathic pain: a double-blind, placebo-controlled, multicenter study.
    Shaibani AI; Pope LE; Thisted R; Hepner A
    Pain Med; 2012 Feb; 13(2):243-54. PubMed ID: 22314263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dextromethorphan/quinidine for the treatment of pseudobulbar affect.
    Patatanian E; Casselman J
    Consult Pharm; 2014 Apr; 29(4):264-9. PubMed ID: 24704895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of dextromethorphan in pain control.
    Weinbroum AA; Rudick V; Paret G; Ben-Abraham R
    Can J Anaesth; 2000 Jun; 47(6):585-96. PubMed ID: 10875724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of NMDA antagonist in perioperative pain management.
    Chan KH
    Acta Anaesthesiol Sin; 1999 Dec; 37(4):171-2. PubMed ID: 10670113
    [No Abstract]   [Full Text] [Related]  

  • 12. Dextromethorphan and quinidine combination for heroin detoxification.
    Akerele E; Bisaga A; Sullivan MA; Garawi F; Comer SD; Thomas AA; Nunes EV; Kleber HD
    Am J Addict; 2008; 17(3):176-80. PubMed ID: 18463993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [NMDA receptor antagonists: a new treatment for neuropathic pain].
    Pud D; Eisenberg E
    Harefuah; 1999 Apr; 136(7):564-7. PubMed ID: 15532603
    [No Abstract]   [Full Text] [Related]  

  • 14. Response to Dr. Rosenquist's comments pertaining to the paper by Andaloro et al. ('98) "Dextromethorphan and other N-methyl-D-aspartate receptor antagonists are teratogenic in the avian embryo model" and letters to the editor by Polifka JE and Shepard TH ('98) and Brent RL ('98).
    Brent RL; Shepard TH; Polifka JE
    Teratology; 1999 Aug; 60(2):61-2. PubMed ID: 10440776
    [No Abstract]   [Full Text] [Related]  

  • 15. Dextromethorphan and quinidine in adult patients with uncontrolled painful diabetic peripheral neuropathy: a 29-day, multicenter, open-label, dose-escalation study.
    Thisted RA; Klaff L; Schwartz SL; Wymer JP; Culligan NW; Gerard G; Pope LE; Berg JE
    Clin Ther; 2006 Oct; 28(10):1607-18. PubMed ID: 17157116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical benefits and risks of N-methyl-d-aspartate receptor antagonists to treat severe opioid use disorder: A systematic review.
    Fluyau D; Revadigar N; Pierre CG
    Drug Alcohol Depend; 2020 Mar; 208():107845. PubMed ID: 31978670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous malformations associated with central pain: report of a case.
    Cohen SP; Abdi S
    Anesth Analg; 2002 Nov; 95(5):1358-60, table of contents. PubMed ID: 12401626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of dextromethorphan and cyclosporine a for acute encephalopathy.
    Matsuo M; Maeda T; Ono N; Sugihara S; Kobayashi I; Koga D; Hamasaki Y
    Pediatr Neurol; 2013 Mar; 48(3):200-5. PubMed ID: 23419470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of dextromethorphan administration in 18 patients with subacute methotrexate central nervous system toxicity.
    Afshar M; Birnbaum D; Golden C
    Pediatr Neurol; 2014 Jun; 50(6):625-9. PubMed ID: 24742799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMDA receptor antagonists: tools in neuroscience with promise for treating CNS pathologies.
    Köhr G
    J Physiol; 2007 May; 581(Pt 1):1-2. PubMed ID: 17331982
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.